Viking Global Investors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-721,926
Closed -$45.7M 101
2024
Q3
$45.7M Sell
721,926
-632,524
-47% -$40M 0.17% 74
2024
Q2
$71.8M Buy
1,354,450
+259,510
+24% +$13.8M 0.28% 62
2024
Q1
$89.8M Sell
1,094,940
-4,050,172
-79% -$332M 0.33% 57
2023
Q4
$95.8M Buy
5,145,112
+571,796
+13% +$10.6M 0.35% 58
2023
Q3
$50.6M Buy
4,573,316
+1,028,810
+29% +$11.4M 0.21% 66
2023
Q2
$57.5M Buy
3,544,506
+1,589,443
+81% +$25.8M 0.24% 71
2023
Q1
$32.6M Buy
+1,955,063
New +$32.6M 0.15% 70